Literature DB >> 31342250

An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.

Bao-Yong Zhou1, Jun-Hua Gong2,3, Xiao-Yan Cai4, Jia-Xing Wang5, Fang Luo1, Ning Jiang6, Jian-Ping Gong2,3, Cheng-You Du1, Rui Liao7.   

Abstract

PURPOSE: The diagnostic potential of hepatic stellate cells (HSCs) and γδT cells for patients with hepatocellular carcinoma (HCC) and their synergistic contributions to the prognosis of these patients have not yet been investigated. The aim of this study was to elucidate the prognostic value of these cells in HCC.
METHODS: The prognostic significance of the ratio of HSCs to γδT cells (SGR) was assessed in a total of 339 HCC patients undergoing resection. The correlation between the circulating tumor cell (CTC) level and SGR in 71 HCC patients was determined using the CellSearch system. In vitro experiments were performed to validate the synergistic effects of HSCs and γδT cells on hepatoma cells.
RESULTS: Peritumoral SGR was closely associated with overall survival (OS) and recurrence-free survival (RFS) of HCC patients after resection. In the testing cohort, two nomograms incorporating the SGR were constructed for the prediction of OS and RFS. The predictive accuracy of the two nomograms was verified by the validation cohort. CTC levels were positively correlated with SGR (r = 0.479, p < 0.001). Among the patients with CTCs > 2/7.5 ml, those with a high SGR exhibited higher early recurrence rates than those with a low SGR. In vitro experiments revealed that the secretion of INF-γ, IL-17, and TNF-α from γδT cells was increased after culture with HSC-conditioned medium. In addition, γδT cells cultured with HSC-conditioned medium decreased the proliferative and invasive abilities of hepatoma cells.
CONCLUSIONS: The peritumoral SGR is related to aggressive tumor behavior and has a powerful predictive value in HCC. Early recurrence in patients with a high peritumoral SGR might be associated with high CTC levels.

Entities:  

Keywords:  Circulating tumor cell; Hepatic stellate cell; Hepatocellular carcinoma; Prognosis; γδT cell

Mesh:

Year:  2019        PMID: 31342250     DOI: 10.1007/s12072-019-09969-w

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  8 in total

1.  Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages.

Authors:  Moulay Yassine Belghali; Brahim Admou; Maroua Brahimi; Mouna Khouchani; Saadia Ba-M'hamed
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

Review 2.  Role of γδT cells in liver diseases and its relationship with intestinal microbiota.

Authors:  Qi-Hui Zhou; Feng-Tian Wu; Lan-Tian Pang; Tian-Bao Zhang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

3.  MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.

Authors:  Yunhong Xia; Lu Zhen; Hongxia Li; Shuomin Wang; Sun Chen; Chongchong Wang; Xiaoyu Yang
Journal:  Cell Death Dis       Date:  2021-03-26       Impact factor: 8.469

Review 4.  The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma.

Authors:  Fang Wang; Greg Malnassy; Wei Qiu
Journal:  Front Oncol       Date:  2021-03-15       Impact factor: 6.244

Review 5.  The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.

Authors:  Yang Li; Gen Li; Jian Zhang; Xiaoli Wu; Xi Chen
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

Review 6.  Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection.

Authors:  Wen Hou; Xiaoli Wu
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

7.  Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.

Authors:  Rui Liao; Xu-Fu Wei; Ping Che; Kun-Li Yin; Lei Liu
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

8.  Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3.

Authors:  Yaping Xu; Yihao Huang; Wanqiong Xu; Xiaohui Zheng; Xue Yi; Liyue Huang; Yuxiao Wang; Kangni Wu
Journal:  Onco Targets Ther       Date:  2020-02-18       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.